Forward Pharma Operations ApS: Financial statements 2020
CVR: 38757504
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Forward Pharma Operations ApS (CVR 38757504) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 351,024 and a net result of DKK -10,108,937 compared with DKK -7,546,712 the year before. That is an increase of 7.4% compared with the year before. The profit margin was -2,879.8%. Equity in the 2020 report amounted to DKK 314,592,318. The solvency ratio was 93.3%.
- Revenue
- DKK 351,024
- Gross Profit
- DKK -8,158,312
- Profit/Loss
- DKK -10,108,937
- Equity
- DKK 314,592,318
- Total Assets
- DKK 337,159,158
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 351 t. | -8.2 mio. | -10.1 mio. | 314.6 mio. | - |
| 2019 | 327 t. | -11.3 mio. | -7.5 mio. | 324.7 mio. | - |
| 2018 | 105 t. | -27.1 mio. | -15.8 mio. | 332.2 mio. | - |
Official annual report
How creditworthy is Forward Pharma Operations ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Forward Pharma Operations ApS has published its annual report for 2019. Revenue came to DKK 326,709, and the net result was DKK -7,546,712.
About Forward Pharma Operations ApS
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.